The population impact of human papillomavirus vaccination on circulating genotypes

人乳头瘤病毒疫苗接种对循环基因型的人群影响

• 批准号: nhmrc : 1007685
• 负责人: A/Pr Julia Brotherton
• 金额: $ 16.62万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/population-impact-human-circulating-genotypes/109239
• 关键词: population; impact; human; papillomavirus; vaccination

Infection with human papillomavirus (HPV) is very common. Persistent infection can cause abnormal changes to cervical cells as found on Pap smears and if untreated, over time can develop into cervical cancer. Recently, a vaccine was introduced in Australia for women aged 12-26. To monitor the effectiveness of this vaccine, young women aged 18-22 will be asked to self-collect a sample for HPV detection which will determine if HPV types targeted by vaccine are reducing in prevalence.

感染人乳头瘤病毒(HPV)是非常常见的。持续感染会导致宫颈细胞异常变化，如巴氏涂片所示，如果不治疗，随着时间的推移，可能会发展为宫颈癌。最近，澳大利亚推出了一种针对12-26岁女性的疫苗。为了监测这种疫苗的有效性，18-22岁的年轻女性将被要求自行收集HPV检测样本，以确定疫苗针对的HPV类型的流行率是否正在下降。